ARCT vs BIIB: Which Stock is Better?
Side-by-side comparison of Arcturus Therapeutics Holdings Inc and Biogen Inc in 2026
ARCT
Arcturus Therapeutics Holdings Inc
$6.39
BIIB
Biogen Inc
$185.29
Key Metrics Comparison
| Metric | ARCT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $181.62M | $27.19B | BIIB |
| P/E Ratio | N/A | 21.10 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | -0.7% | -0.1% | BIIB |
| Gross Margin | -36.8% | 78.9% | BIIB |
Analyze ARCT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARCT or BIIB a better investment?
Comparing ARCT and BIIB: Arcturus Therapeutics Holdings Inc has a market cap of $181.62M while Biogen Inc has $27.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARCT and BIIB?
ARCT (Arcturus Therapeutics Holdings Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARCT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARCT or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.7% for ARCT.
Which company is more profitable: ARCT or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -36.8% for ARCT.
Which is the larger company: ARCT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.19B compared to $181.62M for ARCT.
Should I buy ARCT or BIIB in 2026?
Both ARCT and BIIB have investment merit. ARCT trades at $6.39 while BIIB trades at $185.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARCT and BIIB stock?
Key differences: Market Cap ($181.62M vs $27.19B), P/E Ratio (N/A vs 21.1x), Revenue Growth (-0.7% vs -0.1%), Gross Margin (-36.8% vs 78.9%).